Astrana Health (NASDAQ:ASTH – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01), Briefing.com reports. Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The firm had revenue of $404.36 million during the quarter, compared to the consensus estimate of $413.84 million. During the same period last year, the business earned $0.42 earnings per share. The business’s revenue was up 19.9% compared to the same quarter last year. Astrana Health updated its FY24 guidance to $1.28 to $1.52 EPS.
Astrana Health Trading Down 1.0 %
ASTH opened at $37.93 on Wednesday. The company has a market cap of $2.13 billion, a P/E ratio of 28.74, a PEG ratio of 1.20 and a beta of 1.12. The business has a 50 day simple moving average of $40.36. Astrana Health has a 12 month low of $28.86 and a 12 month high of $45.71. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.11 and a current ratio of 2.11.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on ASTH shares. Truist Financial boosted their price target on Astrana Health from $41.00 to $44.00 and gave the stock a “hold” rating in a report on Friday, March 1st. Jefferies Financial Group assumed coverage on shares of Astrana Health in a research note on Monday, February 26th. They set a “buy” rating and a $50.00 target price for the company.
Astrana Health Company Profile
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Further Reading
- Five stocks we like better than Astrana Health
- Stock Splits, Do They Really Impact Investors?
- Celsius Stock’s Post-Earnings Morning Dip, Better than Coffee
- What Makes a Stock a Good Dividend Stock?
- Chegg Chokes on AI Attempt, CEO Talks it Up As He Passes Torch
- About the Markup Calculator
- Does Logitech’s EPS Beat Signal the Rebound of Video Gaming?
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.
